Apolipoprotein E deficiency reduced in vivo hepatic VLDL-triglyceride production by 46% compared to wild-type controls, demonstrating a physiological role for apo E in VLDL secretion.
Apo E-deficient and wild-type control mice utilized for in vivo and in vitro assessment of hepatic VLDL-triglyceride production.
Apolipoprotein E deficiency vs Wild-type control mice
Hepatic VLDL-TG production rate in vivo — reduced by 46%, p=<0.05
Effect estimate: reduced by 46%
Absolute Event Rate: 61.1% vs 112.6%
p-value: p=<0.05
To explore mechanisms underlying triglyceride (TG) accumulation in livers of chow-fed apo E-deficient mice (Kuipers, F., J.M. van Ree, M.H. Hofker, H. Wolters, G. In't Veld, R.J. Vonk, H.M.G. Princen, and L.M. Havekes. 1996. Hepatology. 24:241-247), we investigated the effects of apo E deficiency on secretion of VLDL-associated TG (a) in vivo in mice, (b) in isolated perfused mouse livers, and (c) in cultured mouse hepatocytes. (a) Hepatic VLDL-TG production rate in vivo, determined after Triton WR1339 injection, was reduced by 46% in apo E-deficient mice compared with controls. To eliminate the possibility that impaired VLDL secretion is caused by aspecific changes in hepatic function due to hypercholesterolemia, VLDL-TG production rates were also measured in apo E-deficient mice after transplantation of wild-type mouse bone marrow. Bone marrow- transplanted apo E-deficient mice, which do not express apo E in hepatocytes, showed normalized plasma cholesterol levels, but VLDL-TG production was reduced by 59%. (b) VLDL-TG production by isolated perfused livers from apo E-deficient mice was 50% lower than production by livers from control mice. Lipid composition of nascent VLDL particles isolated from the perfusate was similar for both groups. (c) Mass VLDL-TG secretion by cultured apo E-deficient hepatocytes was reduced by 23% compared with control values in serum-free medium, and by 61% in the presence of oleate in medium (0. 75 mM) to stimulate lipogenesis. Electron microscopic evaluation revealed a smaller average size for VLDL particles produced by apo E-deficient cells compared with control cells in the presence of oleate (38 and 49 nm, respectively). In short-term labeling studies, apo E-deficient and control cells showed a similar time-dependent accumulation of 3HTG formed from 3Hglycerol, yet secretion of newly synthesized VLDL-associated 3HTG by apo E-deficient cells was reduced by 60 and 73% in the absence and presence of oleate, respectively. We conclude that apo E, in addition to its role in lipoprotein clearance, has a physiological function in the VLDL assembly-secretion cascade.
Building similarity graph...
Analyzing shared references across papers
Loading...
Folkert Kuipers
General / Preventive / Lipids
M.C.M. de Jong
Landesbank Baden-Württemberg
Yuguang Lin
Journal of Clinical Investigation
University of Groningen
Leiden University
Center for Digestive and Liver Diseases
Building similarity graph...
Analyzing shared references across papers
Loading...
Kuipers et al. (Mon,) conducted a other in Apolipoprotein E deficiency. Apolipoprotein E deficiency vs. Wild-type control mice was evaluated on Hepatic VLDL-TG production rate in vivo (reduced by 46%, p=<0.05). Apolipoprotein E deficiency reduced in vivo hepatic VLDL-triglyceride production by 46% compared to wild-type controls, demonstrating a physiological role for apo E in VLDL secretion.
synapsesocial.com/papers/6a21569b5c0c8498e257e9e7 — DOI: https://doi.org/10.1172/jci119841